New patent expiration for Novartis drug PATANASE

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for PATANASE
Annual Drug Patent Expirations for PATANASE

Patanase is a drug marketed by Novartis and is included in one NDA. It is available from two suppliers. There are two patents protecting this drug and one Paragraph IV challenge.

PATANASE drug price trends.

Drug patent litigation for PATANASE.

The generic ingredient in PATANASE is olopatadine hydrochloride. Two suppliers are listed for this compound. Additional details are available on the olopatadine hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top